Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$12.57 - $21.22 $226,360 - $382,129
-18,008 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$8.73 - $14.56 $136,100 - $226,990
-15,590 Reduced 46.4%
18,008 $238,000
Q3 2020

Nov 13, 2020

SELL
$8.56 - $11.6 $424,892 - $575,789
-49,637 Reduced 59.63%
33,598 $296,000
Q2 2020

Aug 14, 2020

BUY
$6.63 - $12.85 $92,952 - $180,157
14,020 Added 20.26%
83,235 $832,000
Q1 2020

May 15, 2020

BUY
$6.94 - $14.42 $480,352 - $998,080
69,215 New
69,215 $508,000
Q4 2019

Feb 14, 2020

SELL
$6.23 - $7.98 $362,841 - $464,763
-58,241 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$5.62 - $7.86 $227,817 - $318,620
40,537 Added 228.97%
58,241 $399,000
Q2 2019

Aug 14, 2019

SELL
$4.53 - $7.0 $92,765 - $143,346
-20,478 Reduced 53.63%
17,704 $113,000
Q1 2019

May 15, 2019

BUY
$3.65 - $6.05 $139,364 - $231,001
38,182 New
38,182 $197,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $48.1M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.